Now showing items 1-3 of 3

  • Aerobic interval exercise improves parameters of nonalcoholic fatty liver disease (NAFLD) and other alterations of metabolic syndrome in obese Zucker rats. 

    Kapravelou, Garyfallia; Martinez, Rosario; Andrade, Ana M.; Nebot, Elena; Camiletti-Moiron, Daniel; Aparicio, Virginia A.; Lopez-Jurado, Maria; Aranda, Pilar; Arrebola, Francisco; Fernandez-Segura, Eduardo; Bermano, Giovanna; Goua, Marie; Galisteo, Milagros; Porres, Jesus M. (NRC Research Press https://dx.doi.org/10.1139/apnm-2015-0141, 2015-08-14)
    KAPRAVELOU, G., MARTINEZ, R., ANDRADE, A.M., NEBOT, E., CAMILETTI-MOIRON, D., APARICIO, V.A., LOPEZ-JURADO, M., ARANDA, P., ARREBOLA, F., FERNANDEZ-SEGURA, E., BERMANO, G., GOUA, M., GALISTEO, M. and PORRES, J.M. 2015. Aerobic interval exercise improves parameters of non-alcoholic fatty liver disease (NAFLD) and other alterations of metabolic syndrome in obese Zucker rats. Applied physiology, nutrition, and metabolism [online], 40(12), pages 1242-1252. Available from: https://dx.doi.org/10.1139/apnm-2015-0141
    Metabolic syndrome (MS) is a group of metabolic alterations that increase the susceptibility to cardiovascular disease and type 2 diabetes. Nonalcoholic fatty liver disease has been described as the liver manifestation of ...
  • Different dietary approaches for the treatment of obesity and the phenotypic responses to these diets. 

    Hession, Michelle (The Robert Gordon University Centre for Obesity Research and Epidemiology, Faculty of Health and Social Care, 2009-04)
    Currents treatments for obesity have been unsuccessful. It is essential that a patient-centred approach for obesity management is developed and for this to be successful other diet and lifestyle approaches need to be ...
  • Thinking around abdominal obesity and cardiovascular risk. 

    Broom, Iain (SAGE Publications., 2006-03)
    BROOM, I., 2006. Thinking around abdominal obesity and cardiovascular risk. British Journal of Diabetes and Vascular Disease, 6 (2), pp. 58-61.
    Obesity, particularly abdominal (visceral) obesity, is a burden on healthcare systems worldwide and is a leading cause of cardiovascular disease (CVD), insulin resistance, Type 2 diabetes, dyslipidaemia, metabolic syndrome, ...